Concentrix Corporation ( (CNXC) ) has released its Q4 earnings. Here is a breakdown of the information Concentrix Corporation presented to its investors.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Concentrix Corporation, a global leader in technology and services, designs and implements end-to-end solutions to help businesses enhance their brand experiences and operational efficiencies across various industries.
In its fiscal year 2024 earnings report, Concentrix Corporation announced a noteworthy revenue growth at the high end of its guidance, achieving a 35.2% increase year-on-year. The company also returned $220 million to shareholders through dividends and share repurchases, while introducing new generative AI productivity applications.
Key financial highlights include a revenue of $9.6 billion for the fiscal year, up from $7.1 billion the previous year. Despite the impressive top-line growth, the company’s operating income decreased by 9.8% to $596.4 million, primarily due to investments in its GenAI product suite. The diluted earnings per share also saw a decline from $5.70 to $3.71. However, Concentrix achieved a significant improvement in non-GAAP net income, which increased by 22.5% to $772.3 million.
Strategically, Concentrix is making strides with its GenAI product suite, which has already generated substantial market traction shortly after its launch. Additionally, the company’s board has authorized an increase in its share repurchase program to $600 million, signaling confidence in its growth trajectory.
Looking forward, Concentrix anticipates continued revenue growth and margin expansion in fiscal year 2025. The company projects revenue between $9.47 billion and $9.61 billion, with expectations of improved free cash flow and a focus on leveraging its technology capabilities to drive client success and shareholder value.
